Differentiation
- 60A protein-induced morphogenesis
- Acetylcholinesterase-derived peptides and uses thereof
- Active retinoic acid-free culture medium for chicken embryonic stem cells
- Adipogenic differentiation of human mesenchymal stem cells
- Agonist antibodies
- Agonist antibodies against the flk2/flt3 receptor and uses thereof
- Antibodies to monocyte-colony inhibitory factor (M-CIF)
- Assay for identifying agents which act on the ceramide-activated protein kinase, kinase suppressor of ras, and methods of using said agents
- Bacteriophage vectors generated by bacteriophage/plasmid recombination
- Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
- C-kit ligand-based method for expanding peripheral blood cell levels
- Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
- Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells
- Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells
- Covalent dimer of kit ligand
- D4 gene and methods of use thereof
- D4 gene and methods of use thereof
- Differentiation of granulocytic and monocytic progenitor cells
- Differentiation of whole bone marrow
- Directed differentiation of human embryonic cells
- Efficient construction of gene targeting using phage-plasmid recombination
- Erythropoietin-mediated neurogenesis
- Expression of heterologous genes according to a targeted expression profile
- Gene encoding MNR2 and uses thereof
- Generation of hematopoietic cells from multipotent neural stem cells
- Hematopoietic differentiation of human pluripotent embryonic stem cells
- High dose radionuclide complexes for bone marrow suppression
- High dose radionuclide complexes for bone marrow suppression
- In situ maturation of cultured pancreatic stem cells having a specified, intermediate stage of development
- In vitro generation of differentiated neurons from cultures of mammalian multipotential CNS stem cells
- In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
- In Vivo production and delivery of insulinotropin for gene therapy
- In vivo production and delivery of insulinotropin for gene therapy
- In-vitro-derived human neutrophil precursor cells
- Indexed library of cells containing genomic modifications and methods of making and utilizing the same
- Islet cells from human embryonic stem cells
- Method for differentiating rat hepatic stem cells to insulin-producing cells
- Method for generating dopaminergic cells derived from neural precursors
- Method for increasing platelets by administering soluble interleukin-6 receptor
- Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells
- Method for neural stem cell differentiation using valproate
- Method for preparing a mammalian cell deficient in HPRT
- Method for remyelinating a demyelinized lesion due to injury in the brain or spinal cord
- Method for treating asthma using SCF antibody
- Method for treating mammals with monopegylated proteins that stimulates megakaryocyte growth and differentiation
- Method of differentiating erythrocyte progenitor cells
- Method of making embryoid bodies from primate embryonic stem cells
- Method of reconstituting human lymphoid and dendritic cells
- Methods and compositions for obtaining mature dendritic cells
- Methods for differentiating neural stem cells to glial cells using
- Methods for enhanced retroviral-mediated gene transfer
- Methods for inhibiting mastocytosis
- Methods of controlling proliferation and differentiation of stem and progenitor cells
- Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
- Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
- OP-3 induced morphogenesis
- Primate embryonic stem cells
- Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
- Production of megakaryocytes by the use of human mesenchymal stem cells
- Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
- Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
- Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
- Retroviral gene therapy vectors and therapeutic methods based thereon
- Serum-derived factor inducing cell differentiation and medical uses thereof
- Skeletal-targeted radiation to treat bone-associated pathologies
- TEC promoter
- Transdifferentiation of glial cells
- Transgenic mouse having a disrupted amyloid precursor protein gene
- Use of adipsin/complement factor D in the treatment of metabolic related disorders
- Use of mCRP to slow cell growth and to promote maturation of cells